Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Di | Movano-Aktie erreicht 52-Wochen-Tief bei 3,01 US-Dollar | 1 | Investing.com Deutsch | ||
Di | Movano stock hits 52-week low at $3.01 amid market challenges | 1 | Investing.com | ||
MOVANO Aktie jetzt für 0€ handeln | |||||
Fr | Movano Inc. (NASDAQ:MOVE) Q3 2024 Earnings Call Transcript | 3 | Insider Monkey | ||
14.11. | Movano Health Reports Q3 2024 Financial Results and Provides Business Update | 50 | PR Newswire | Highlights successful Evie Ring back-in-stock execution
Updates status of EvieMED 510(k) application review
Focuses on launch of EvieMED and securing B2B opportunities... ► Artikel lesen | |
13.11. | Movano's Earnings: A Preview | 1 | Benzinga.com | ||
07.11. | Movano Health Announces Completion of Clinical Study with Cuffless RF Blood Pressure Device | 53 | PR Newswire | New hardware boasts significant improvements to reduce noise and generate higher fidelity signals
PLEASANTON, Calif., Nov. 7, 2024 /PRNewswire/ -- Movano Health... ► Artikel lesen | |
04.11. | Movano Health Submits Response to FDA as Part of Final Review Phase for EvieMED | 51 | PR Newswire | Company remains optimistic on the potential for this pioneering healthcare solution
PLEASANTON, Calif., Nov. 4, 2024 /PRNewswire/ -- Movano Health (NASDAQ: MOVE)... ► Artikel lesen | |
04.11. | Movano Health Provides Update on Investigation to Expose Apparent Stock Manipulation Following Reverse Stock Split | 56 | PR Newswire | Company Continues to Work with Securities Regulators, Legal Advisors and Other Partners to Protect Interests of Shareholders
PLEASANTON, Calif., Nov. 4, 2024... ► Artikel lesen | |
31.10. | Movano Health probes stock manipulation after reverse split | 1 | Investing.com | ||
31.10. | Movano Health Opens Investigation to Expose Apparent Stock Manipulation Following Reverse Stock Split | 58 | PR Newswire | Company Communicating with Securities Regulators, Legal Advisors and Other Partners to Protect Interests of Shareholders
PLEASANTON, Calif., Oct. 31, 2024 /PRNewswire/... ► Artikel lesen | |
30.10. | Movano stock hits 52-week low at $3.53 amid market challenges | 1 | Investing.com | ||
25.10. | Movano Health kündigt Aktienzusammenlegung im Verhältnis 1:15 an | 2 | Investing.com Deutsch | ||
25.10. | Movano Health announces 1-for-15 reverse stock split | 2 | Investing.com | ||
25.10. | Movano Inc. - 8-K, Current Report | 1 | SEC Filings | ||
25.10. | Movano Health Announces Reverse Stock Split | 73 | PR Newswire | Shares Expected to Begin Trading on Split-Adjusted Basis on October 29, 2024
PLEASANTON, Calif., Oct. 25, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE)... ► Artikel lesen | |
24.10. | Movano Health nähert sich der letzten Phase der FDA-Prüfung für den EvieMED-Ring | 1 | Investing.com Deutsch | ||
24.10. | Movano Health Plans Response Submission to FDA Next Week as Part of EvieMED Final Review Phase | 46 | PR Newswire | A successful response to requests for additional information would bring the Company one step closer to introducing this pioneering healthcare product to the market
PLEASANTON, Calif., Oct. 24,... ► Artikel lesen | |
10.10. | Movano Health nears FDA clearance for EvieMED Ring | 1 | Investing.com | ||
10.10. | Movano Health kurz vor FDA-Zulassung für EvieMED Ring | 2 | Investing.com Deutsch | ||
10.10. | Movano Health Provides Update on FDA Review of EvieMED Ring | 81 | PR Newswire | The Company continues to work closely with the FDA to bring this pioneering healthcare product to market
PLEASANTON, Calif., Oct. 10, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) announced... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
EMEIS | 5,705 | +1,44 % | emeis: Upturn in Performance Confirmed in Third-Quarter 2024 | Revenue up +8.3%, occupancy rate up +2.6 points
Regulatory News:
emeis (Paris:EMEIS):
Growth in all core activities and in all geographical areas (revenue and occupancy rate)
Solid... ► Artikel lesen | |
NANO-X IMAGING | 5,650 | -4,07 % | Nano-X Imaging Ltd reports results for the quarter ended September 30 - Earnings Summary | ||
BUTTERFLY NETWORK | 3,235 | -2,71 % | BFLY-Aktie erreicht 52-Wochen-Hoch bei 2,95 US-Dollar | ||
GOODRX | 4,330 | +0,46 % | GoodRx Holdings one of the most undervalued stocks, Leerink says | ||
TALKSPACE | 3,225 | +2,06 % | Espresa Partners with Talkspace to Boost Employee Well-Being with Accessible Mental Health Benefits | Espresa has partnered with Talkspace to expand mental health support for employees. Through Espresa's platform, clients now have access to Talkspace's 5,000+ licensed therapists, offering secure, on-demand... ► Artikel lesen | |
CARMAT | 1,190 | -1,00 % | CARMAT's Aeson Artificial Heart Is Gradually Becoming a Reference Solution for Bridge to Transplant in Europe | Milestone of 30 heart transplants post Aeson® support, passed Strong interest in Aeson® from the medical community: more than 100 European experts will share their experience at the first... ► Artikel lesen | |
JOINT CORP | 11,095 | -1,90 % | JYNT's Q3 Earnings Meet Estimates Amid Higher Costs, Shares Dip 3% | ||
MIMEDX | 9,180 | +1,21 % | MIMEDX GROUP, INC. - 8-K, Current Report | ||
HYPERFINE | 0,900 | 0,00 % | Hyperfine, Inc. Reports Third Quarter 2024 Financial Results | GUILFORD, Connecticut, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable... ► Artikel lesen | |
PROCEPT BIOROBOTICS | 92,70 | 0,00 % | Looking Into PROCEPT BioRobotics' Recent Short Interest | ||
BIOMERICA | 0,311 | -2,81 % | Biomerica secures patents for GI treatments in Europe | ||
ATRICURE | 36,100 | +0,19 % | Pre-market Movers: ASP Isotopes, NerdWallet, Reddit, AtriCure, Qorvo | OLATHE (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.05 A.M. ET).In the Green ASP Isotopes Inc. (ASPI) is up over 44% at $8.33.
NerdWallet... ► Artikel lesen | |
PROGYNY | 14,340 | +2,58 % | Barclays Lowers Progyny (NASDAQ:PGNY) Price Target to $17.00 | ||
LIFEMD | 5,620 | +4,07 % | LifeMD, Inc.: LifeMD Reports Third Quarter 2024 Results | Total revenues increased 38% year-over-year to $53.4 million with telehealth revenue up 65%Record gross margin of 90.6%, up 300 basis points from the year-ago periodAdjusted EBITDA increased 33% to... ► Artikel lesen | |
PROPHASE LABS | 0,690 | +0,73 % | ProPhase Labs, Inc. (NASDAQ:PRPH) Q3 2024 Earnings Call Transcript |